Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Tønnesen, Jan ^a   Parish, Clare L ^b,d   Sørensen, Andreas T ^a   Andersson, Angelica ^a   Lundberg, Cecilia ^a   Deisseroth, Karl ^c   Arenas, Ernest ^b   Lindvall, Olle ^a   Kokaia, Merab ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Stanford University   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE AUTORECEPTOR; HALORHODOPSIN; RHODOPSIN; WNT5A PROTEIN; CHANNELRHODOPSIN 2, MOUSE; DOPAMINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE ACTIVATION; MOLECULAR GENETICS; MOUSE; NERVE CELL INHIBITION; NERVE GRAFT; NERVE POTENTIAL; NEURAL STEM CELL; NONHUMAN; OPTOGENETICS; PARKINSON DISEASE; PATCH CLAMP; POSTSYNAPTIC POTENTIAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; ACTION POTENTIAL; ANIMAL; BIOLOGICAL MODEL; CELL SHAPE; CYTOLOGY; IN VITRO STUDY; MESENCEPHALON; METABOLISM; METHODOLOGY; NERVE CELL; OPTICS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE; TRANSPLANTATION;

ANIMALIA; MUS MUSCULUS;

ACTION POTENTIALS; ANIMALS; CELL SHAPE; DOPAMINE; MESENCEPHALON; MICE; MODELS, BIOLOGICAL; NEURAL STEM CELLS; NEURONS; OPTICS AND PHOTONICS; PARKINSON DISEASE; RHODOPSIN; SYNAPSES;

EID: 79952353120     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017560     Document Type: Article

References (38)

1. Lindvall O, Bjorklund A, (2004) Cell therapy in Parkinson's disease. NeuroRx 1: 382-393.
2. Lindvall O, Kokaia Z, (2006) Stem cells for the treatment of neurological disorders. Nature 441: 1094-1096.
3. Lindvall O, Kokaia Z, (2009) Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 30: 260-267.
4. Friling S, Andersson E, Thompson LH, Jonsson ME, Hebsgaard JB, et al. (2009) Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci U S A 106: 7613-7618.
5. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, et al. (2002) Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418: 50-56.
6. Inestrosa NC, Arenas E, (2010) Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 11: 77-86.
7. Parish CL, Castelo-Branco G, Rawal N, Tonnesen J, Sorensen AT, et al. (2008) Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest 118: 149-160.
8. Plenz D, Aertsen A, (1996) Neural dynamics in cortex-striatum co-cultures-II. Spatiotemporal characteristics of neuronal activity. Neuroscience 70: 893-924.
9. Kearns SM, Scheffler B, Goetz AK, Lin DD, Baker HD, et al. (2006) A method for a more complete in vitro Parkinson's model: slice culture bioassay for modeling maintenance and repair of the nigrostriatal circuit. J Neurosci Methods 157: 1-9.
10. Sawamoto K, Nakao N, Kobayashi K, Matsushita N, Takahashi H, et al. (2001) Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proc Natl Acad Sci U S A 98: 6423-6428.
11. Jomphe C, Bourque MJ, Fortin GD, St-Gelais F, Okano H, et al. (2005) Use of TH-EGFP transgenic mice as a source of identified dopaminergic neurons for physiological studies in postnatal cell culture. J Neurosci Methods 146: 1-12.
12. Sarkis C, Serguera C, Petres S, Buchet D, Ridet JL, et al. (2000) Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci U S A 97: 14638-14643.
13. Ahlenius H, Visan V, Kokaia M, Lindvall O, Kokaia Z, (2009) Neural stem and progenitor cells retain their potential for proliferation and differentiation into functional neurons despite lower number in aged brain. J Neurosci 29: 4408-4419.
14. Cronberg T, Rytter A, Asztely F, Soder A, Wieloch T, (2004) Glucose but not lactate in combination with acidosis aggravates ischemic neuronal death in vitro. Stroke 35: 753-757.
15. Stoppini L, Buchs PA, Muller D, (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37: 173-182.
16. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K, (2005) Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 8: 1263-1268.
17. Zhang F, Wang LP, Boyden ES, Deisseroth K, (2006) Channelrhodopsin-2 and optical control of excitable cells. Nat Methods 3: 785-792.
18. Zhang F, Wang LP, Brauner M, Liewald JF, Kay K, et al. (2007) Multimodal fast optical interrogation of neural circuitry. Nature 446: 633-639.
19. Tonnesen J, Sorensen AT, Deisseroth K, Lundberg C, Kokaia M, (2009) Optogenetic control of epileptiform activity. Proc Natl Acad Sci U S A 106: 12162-12167.
20. Jakubs K, Nanobashvili A, Bonde S, Ekdahl CT, Kokaia Z, et al. (2006) Environment matters: synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability. Neuron 52: 1047-1059.
21. Lacey MG, Mercuri NB, North RA, (1989) Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J Neurosci 9: 1233-1241.
22. Neuhoff H, Neu A, Liss B, Roeper J, (2002) I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci 22: 1290-1302.
23. Tecuapetla F, Patel JC, Xenias H, English D, Tadros I, et al. (2010) Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens. J Neurosci 30: 7105-7110.
24. Fasano C, Thibault D, Trudeau LE, (2008) Culture of postnatal mesencephalic dopamine neurons on an astrocyte monolayer. Curr Protoc Neurosci Chapter 3: Unit 3 21.
25. Joyce MP, Rayport S, (2000) Mesoaccumbens dopamine neuron synapses reconstructed in vitro are glutamatergic. Neuroscience 99: 445-456.
26. Mercuri NB, Calabresi P, Bernardi G, (1992) The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. Life Sci 51: 711-718.
27. Grace AA, Onn SP, (1989) Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci 9: 3463-3481.
28. Tepper JM, Lee CR, (2007) GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 160: 189-208.
29. Cherubini E, Gaiarsa JL, Ben-Ari Y, (1991) GABA: an excitatory transmitter in early postnatal life. Trends Neurosci 14: 515-519.
30. Leinekugel X, Khalilov I, McLean H, Caillard O, Gaiarsa JL, et al. (1999) GABA is the principal fast-acting excitatory transmitter in the neonatal brain. Adv Neurol 79: 189-201.
31. Piccini P, Lindvall O, Bjorklund A, Brundin P, Hagell P, et al. (2000) Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 48: 689-695.
32. Iversen LL, (2010) Dopamine handbook. New York; Oxford Oxford University Press pp. xvi, 615.
33. Sorensen AT, Thompson L, Kirik D, Bjorklund A, Lindvall O, et al. (2005) Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts. Eur J Neurosci 21: 2793-2799.
34. Uchida K, Momiyama T, Okano H, Yuzaki M, Koizumi A, et al. (2005) Potential functional neural repair with grafted neural stem cells of early embryonic neuroepithelial origin. Neurosci Res 52: 276-286.
35. Fisher LJ, Young SJ, Tepper JM, Groves PM, Gage FH, (1991) Electrophysiological characteristics of cells within mesencephalon suspension grafts. Neuroscience 40: 109-122.
36. Nisenbaum ES, Berger TW, Grace AA, (1992) Presynaptic modulation by GABAB receptors of glutamatergic excitation and GABAergic inhibition of neostriatal neurons. J Neurophysiol 67: 477-481.
37. Nisenbaum ES, Berger TW, Grace AA, (1993) Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynaptic GABAB receptors. Synapse 14: 221-242.
38. Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, et al. (2010) Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med 2: 38ra46.